News & Perspective
Academy
Video New

Specialty: Psychiatry
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Medical Students
Nurses
Pharmacists
Residents
Today on Medscape
Edition: ENGLISH
Edition: ENGLISH

No Results

    Allergy & Immunology Anesthesiology Business of Medicine Cardiology Critical Care Dermatology Diabetes & Endocrinology Emergency Medicine Family Medicine Gastroenterology General Surgery Hematology - Oncology HIV/AIDS Infectious Diseases Internal Medicine Multispecialty Nephrology Neurology Ob/Gyn & Women's Health Oncology Ophthalmology Orthopedics Pathology & Lab Medicine Pediatrics Plastic Surgery Psychiatry Public Health Pulmonary Medicine Radiology Rheumatology Transplantation Urology Medical Students Nurses Pharmacists Residents Today on Medscape
    News & Perspective Academy Video New

    Psychiatry News

    More
    • MD's Appeal in PHP, Medical Board Lawsuit Denied An appeal by a physician whose lawsuit against the North Carolina PHP and the state medical board was thrown out by a lower court has been denied. But Kernan Manion is pursuing another route to justice.
      Medscape Medical News, September 19, 2017
    • Alert FDA Clears Liquid Extended-Release Amphetamine for ADHD Adzenys ER, a liquid extended-release amphetamine product, is another treatment option for patients aged 6 years and older with attention-deficit/hyperactivity disorder (ADHD).
      FDA Approvals, September 19, 2017
    • Leaders Move to Tackle Burnout in Neurology, Psychiatry Leaders in psychiatry and neurology meet to discuss factors contributing to physician burnout and what can be done to promote wellness in the medical profession.
      Medscape Medical News, September 19, 2017
    • Alert FDA Clears New Spinal Stimulation Device for Intractable Pain The FDA has approve the Intellis spinal cord stimulation platform for the management of chronic intractable pain of the trunk and/or limbs associated with a variety of conditions.
      FDA Approvals, September 18, 2017
    • Alert CHMP Backs Two Drugs for Opioid Abuse The EMA committee recommends naloxone nasal spray (Nyxoid) for treatment of opioid overdose and buprenorphine plus naloxone sublingual tablets (Zubsolv) for treatment of opioid dependence.
      International Approvals, September 15, 2017
     

    Columnists

    Today on Medscape

    Top Stories from Across Medicine
    More

    Top Medical News from Across Medscape

    • 'MAP' Program Improves Hypertension ControlThe MAP program focuses on an accurate BP, intensifying treatment when an elevated BP is confirmed, and partnering with the patient to select and carry out the treatment plan.
      Medscape Medical News, September 19, 2017
    • FDA Approves Trelegy Ellipta for COPDThe FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.
      Medscape Medical News, September 19, 2017
    • AAP Offers First Guidance on Tattoos, PiercingsThe report from the American Academy of Pediatrics (AAP) is designed to facilitate conversations between providers, parents, and patients about the increasingly common desire for body modifications.
      Medscape Medical News, September 19, 2017
    • Standards for Upper GI Endoscopy ReleasedThe BSG and AUGIS jointly released recommendations to improve the quality of upper gastrointestinal endoscopy and reduce the risk for missed early cancerous lesions.
      Medscape Medical News, September 19, 2017

    Perspective

    Business of Medicine

    More

    Advisory Board

     

    Medscape Editor-in-Chief

    • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
    Medscape Staff
    анаполон курс

    comprare sildenafil citrate

    acquistare levitra on-line

    Купить Сиалис софт

    Find Us On

    About

    About Medscape Privacy Policy Terms of Use Advertising Policy

    Membership

    Apps

    Medscape MedPulse News CME & Education

    WebMD Network

    Editions

    English
    All material on this website is protected by copyright, Copyright © 1994-2017 by WebMD LLC. This website also contains material copyrighted by 3rd parties.
    Medscape Video NEW Clinical. Captivating. Award-Winning.  Explore Now